Treatment of acute pulmonary embolism as outpatients or following early discharge - A systematic review

Journal:Thrombosis and Haemostasis
ISSN:0340-6245
DOI:http://dx.doi.org/10.1160/TH08-05-0319
Issue:2008: 100/5 (Nov) pp. 727-954
Pages:756-761

Treatment of acute pulmonary embolism as outpatients or following early discharge - A systematic review

Muhammad Janjua1,2, Aaref Badshah2, Fadi Matta2, Liviu G. Danescu2, Abdo Y. Yaekoub2, Paul D. Stein2,3
1William Beaumont Hospital, Royal Oak, Michigan, USA; 2St. Joseph Mercy Oakland Hospital, Pontiac, Michigan, USA; 3Wayne State University School of Medicine, Detroit, Michigan, USA

Summary

The purpose of this systematic review is to test the hypothesis that carefully selected low-risk patients with acute pulmonary embolism (PE) can safely be treated entirely as outpatients or after early hospital discharge. Included articles were required to describe inclusion or exclusion criteria and outcome of patients treated for PE.Early hospital discharge was defined as an average hospital stay ≤3 days. Six investigations included patients with PE who were treated entirely as outpatients; two investigations included patients with PE who were treated after early discharge. All investigations included only low-risk patients or patients with small or medium sized PE. Outcome after 3-46 months in patients treated entirely as outpatients showed recurrent PE in 0% to 6.2% of patients, major bleeding in 0% to 2.8% with one death from an intracerebral bleed. Definite death from PE did not occur, but there was one possible death from PE. Outcome in three months in patients treated after early discharge showed no instances of recurrent PE. Major bleeding occurred in 0% to 3.7% of patients.There were no deaths from PE, but there was one death from bleeding. In conclusion, outpatient therapy of acute PE is probably safe in low-risk,carefully selected compliant patients who have access to outpatient care if necessary. Such outpatient treatment would be cost-effective.

Keywords

pulmonary embolism, Deep venous thrombosis, outpatient treatment

DOI

http://dx.doi.org/10.1160/TH08-05-0319

You may also be interested in...

1.

H. Leon Daneschvar1, Ali Seddighzadeh1, Gregory Piazza2, Samuel Z. Goldhaber1

Thrombosis and Haemostasis 2008 99 6: 1035-1039

http://dx.doi.org/10.1160/TH08-02-0107

2.

Cihan Ay1,*, Lea V. Jungbauer2,*, Alexandra Kaider3, Silvia Koder1, Simon Panzer4, Ingrid Pabinger1, Christine Mannhalter2

Thrombosis and Haemostasis 2008 99 5: 899-904

http://dx.doi.org/10.1160/TH07-11-0672

3.

Jurga Adomaityte, Maria Farooq, Rehan Qayyum

Thrombosis and Haemostasis 2008 99 2: 338-342

http://dx.doi.org/10.1160/TH07-07-0468



Articles

You've 527 Article(s) in your Basket.

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis

Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...